SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Net Sales | ₹263 Cr | ₹224 Cr | ₹220 Cr | ₹185 Cr | ₹184 Cr |
What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?
Year | Revenue |
---|---|
Mar2024 | ₹263 Cr |
Mar2023 | ₹224 Cr |
Mar2022 | ₹220 Cr |
Mar2017 | ₹185 Cr |
Mar2016 | ₹184 Cr |
How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹263 Cr | 17.45 | |
Mar2023 | ₹224 Cr | 2.09 | |
Mar2022 | ₹220 Cr | 18.85 | |
Mar2017 | ₹185 Cr | 0.50 | |
Mar2016 | ₹184 Cr | - |
Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,727.7 Cr | -2.8% | -4.1% | 23.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -2.8% |
-4.1% |
23.3% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses